Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

in people with muscle-invasive bladder cancer (MIBC) who were not receiving surgery to remove the bladder (cystectomy) and nearby lymph nodes, has been discontinued after it showed no improvement ...

[102] Around 25–30% of muscle invasive bladder cancer patients, who have undergone radical cystectomy, presented with positive lymph nodes at pathologic examination. The approximate disease-free ...

NIAGARA compared Imfinzi plus chemo to chemo alone in muscle-invasive bladder cancer (MIBC) patients scheduled for a cystectomy to remove the bladder. According to the top-line results ...

Localized Muscle-invasive bladder cancer (MIBC) requires definitive treatment with curative intent. A recent systematic review and meta-analysis by Fong et al. compared survival outcomes between ...

Wes Kassouf and Michael O’Donnell discussing optimal treatment sequencing for patients with BCG unresponsive non muscle invasive bladder cancer who decline radical cystectomy. Dr. Black started the ...

AstraZeneca has announced positive high-level results from its Phase III POTOMAC trial assessing the efficacy of IMFINZI® ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized ...